These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10987668)

  • 1. Comparison of anesthetics for inoculation of mice with Chlamydia pneumoniae.
    Erkkilä L; Rottenberg ME; Laitinen K
    Comp Med; 2000 Feb; 50(1):46-8. PubMed ID: 10987668
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
    Penttilä T; Wahlström E; Vuola JM; Sarvas M; Puolakkainen M
    Comp Med; 2006 Aug; 56(4):272-8. PubMed ID: 16941954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental infection of Chlamydia pneumoniae in mice.
    Kaukoranta-Tolvanen SS; Laurila AL; Saikku P; Leinonen M; Liesirova L; Laitinen K
    Microb Pathog; 1993 Oct; 15(4):293-302. PubMed ID: 8309355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establishment and experimental study on mouse model of Chlamydia pneumoniae pneumonitis].
    Shi Y; Yin J; Zhan H
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):592-5. PubMed ID: 11770419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
    Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
    Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
    Skelding KA; Hickey DK; Horvat JC; Bao S; Roberts KG; Finnie JM; Hansbro PM; Beagley KW
    Vaccine; 2006 Jan; 24(3):355-66. PubMed ID: 16153755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.
    Penttilä T; Haveri A; Tammiruusu A; Vuola JM; Lahesmaa R; Puolakkainen M
    Microb Pathog; 2008 Jul; 45(1):25-9. PubMed ID: 18456450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of Chlamydia pneumoniae-type pneumonitis in mice.
    Shi Y; Yin J; Zhan H; Feng G; Zhang X; Su X; Song Y; Xia X; Zhou X; Shen P
    Chin Med J (Engl); 2003 Mar; 116(3):328-32. PubMed ID: 12781030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model.
    Törmäkangas L; Vuorela P; Saario E; Leinonen M; Saikku P; Vuorela H
    Biochem Pharmacol; 2005 Oct; 70(8):1222-30. PubMed ID: 16139801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
    Tammiruusu A; Haveri A; Pascolo S; Lahesmaa R; Stevanovic S; Rammensee HG; Sarvas M; Puolakkainen M; Vuola JM
    Scand J Immunol; 2005 Aug; 62(2):131-9. PubMed ID: 16101819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.
    Törmäkangas L; Erkkilä L; Korhonen T; Tiirola T; Bloigu A; Saikku P; Leinonen M
    Infect Immun; 2005 Oct; 73(10):6458-66. PubMed ID: 16177317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.
    Rodríguez A; Rottenberg M; Tjärnlund A; Fernández C
    Scand J Immunol; 2006 Mar; 63(3):177-83. PubMed ID: 16499570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models for Chlamydia pneumoniae infection.
    Laitinen K; Alakärppä H; Laurila A; Leinonen M
    Scand J Infect Dis Suppl; 1997; 104():15-7. PubMed ID: 9259074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae and atherosclerosis.
    Campbell LA; Kuo CC
    Semin Respir Infect; 2003 Mar; 18(1):48-54. PubMed ID: 12652454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.
    Little CS; Bowe A; Lin R; Litsky J; Fogel RM; Balin BJ; Fresa-Dillon KL
    Infect Immun; 2005 Mar; 73(3):1723-34. PubMed ID: 15731073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice.
    Yang ZP; Kuo CC; Grayston JT
    J Infect Dis; 1995 Mar; 171(3):736-8. PubMed ID: 7876631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy.
    Kuo CC; Lee A; Jiang SJ; Yaraei K; Campbell LA
    Microbes Infect; 2007 Jul; 9(9):1139-41. PubMed ID: 17656142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.
    Yang ZP; Kuo CC; Grayston JT
    Infect Immun; 1993 May; 61(5):2037-40. PubMed ID: 8478091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.